Medicine Chest Axert WHAT: Axert (almotriptan malate), a new, prescription-only member of the triptan family of drugs, from Pharmacia. TREATS: Adults' migraine headaches with or without aura.

The FDA has approved an expanded indication for almotriptan malate (Axert) for the acute treatment of migraine headache in adolescents aged 12 to 17 years. News & Perspective Drugs & Diseases ...

The FDA has approved changes to safety labeling for the estradiol/norethindrone acetate transdermal system (CombiPatch), fluorouracil topical cream (Efudex), oxycodone/aspirin tablets (Percodan ...

Axert has been approved by the FDA for the acute treatment of migraine with or without aura in adults. Axert belongs to a class of drugs known as selective serotonin receptor agonists.Axert ...

Axert® (almotriptan malate) tablets, marketed by Janssen Pharmaceuticals, had annual sales of approximately $31 million in the United States, according to IMS data as of March 2015.

The Teva pharmaceuticals building in Jerusalem. (JNi.media) Israel-based Teva will be the first pharmaceutical company approved to make a generic version of migraine medication Axert. The product ...